FIELD: medicine.
SUBSTANCE: invention refers to chemical-pharmaceutical industry and medicine, namely to solid formulation betahistine dihydrochloride containing lactose, microcrystalline cellulose, copolymer vinylpyrrolidone and vinyl acetate, as well as stearic acid and/or its salts as additives in ratio as specified in the patent claim, and to production procedure of the present formulation.
EFFECT: solid formulation under the invention is characterised with good disintergration and high strength.
6 cl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMBINATION CONTAINING VINPOCETINE AND BETAHISTINE FOR TREATING CEREBRAL CIRCULATORY DEPRESSION | 2008 |
|
RU2386439C2 |
SOLID MEDICINAL FORMULATION POSSESSING HISTAMINE-LIKE EFFECT AND METHOD FOR ITS PREPARING | 2006 |
|
RU2308941C1 |
PHARMACEUTICAL COMPOSITION ELICITING ANTICONVULSANT AND PSYCHOTROPIC EFFECT AND METHOD FOR ITS PREPARING | 2003 |
|
RU2240798C1 |
MODIFIED RELEASE DOSAGE FORM OF TRIMETAZIDINE DIHYDROCHLORIDE | 2009 |
|
RU2412706C1 |
CHEEK POUCH (TRANSBUCCAL) PHARMACEUTICAL COMPOSITION | 2003 |
|
RU2253442C1 |
PHARMACEUTICAL COMPOSITION IN SOLID FORM WITH ANALGESIC ACTIVITY | 2013 |
|
RU2545861C1 |
METHOD OF OBTAINING MEDICAL FORM OF TRIMETAZIDINE OF PROLONGED ACTION | 2012 |
|
RU2530558C2 |
PHARMACEUTICAL COMPOSITION WITH PROLONGED RELEASE WITH ANTIPSYCHOTIC ACTIVITY AND SYNTHESIS METHODS THEREOF | 2012 |
|
RU2584653C2 |
AFOBASOL-BASE PHARMACEUTICAL COMPOSITION | 2004 |
|
RU2289403C2 |
PHARMACEUTICAL COMPOSITION WITH CARDIOSELECTIVE BETA-ADRENERGIC ANTAGONIST (VARIANTS) | 2004 |
|
RU2256447C1 |
Authors
Dates
2009-05-27—Published
2006-12-28—Filed